CLINICAL_TRIALS
trial_result
· 2014-03-14
Clinical Trial Update: Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder [Phase 4]
Summary
Phase 4 safety study of escitalopram in children aged 7 to 11 with major depressive disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-03-14